Funny Pharm: You Write the Caption & Win: November 2013

"Funny Pharm" features drawings by award-winning cartoonist Jerry King. Submit your caption and win!

NovFunnypharmarticle

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

★Winning Caption★
"It was nanotechnology killed the beast." - Bill Russo

Pharmaceutical Manufacturing presents "Funny Pharm," featuring drawings by award-winning cartoonist Jerry King.

The winning cartoon caption will be featured on the PharmaManufacturing.com website and the winner's name will appear in the PharmaManufacturing.com eNewsletter. The winner has a choice of two prizes: a coffee mug with the cartoon and winning caption printed on it OR a $15 Starbucks giftcard.

Please submit your caption to klanghauser@putman.net. Thank you for your contributions!


 Contending Submissions

"It was nanotechnology killed the beast." - Bill Russo

"Read more closely…I said we need a Killer 'APP!'" - Alex Packard

“Love for airplanes doesn’t appear to be in his DNA.” - Douglas G. Williams

"When Wright brothers escape wrath of King Kong." - Mark Lad

“All I wanted to do was file a Product Complaint!” - Sheldon Krocker

“George tends to go a little ape when he doesn’t get his Snickers.” - Leonard Hungiville

"I hope crystallography hath charms to soothe the savage beast." - Bill Russo

"Could either of you gentlemen direct me to Pfizer headquarters?" - Bill Russo

"I'm sorry, ok? These hormones I've been taking have made me a little agressive lately." - Bill Russo

"It’s about time Big Pharma started operating in the cloud." - James Sarzynski

"Our Molecular breeding not only increased our crop yields of feed, but look what it can do for our beef industries." - James Sarzynski

"If I fall, you're paying for my hip replacement... and it could cost billions." -Bill Russo

"Listen, My Molecules just got involved in Reactive Sprouting!" - Naresh Sharma

 

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments